The health care industry has been on a steady growth path for nearly two decades. That’s been good news for investors who have enjoyed almost non-stop gains from the sector. But now, cost pressures are now putting heat on the sector and gains have been much harder to come by. In contrast, the party’s just beginning for China… Chinese health care is far earlier on the growth curve and appears to have a long growth path ahead of itself. Chinese per-capita spending on health care is the lowest of any of the 20 largest global economies. Off… Read More
The health care industry has been on a steady growth path for nearly two decades. That’s been good news for investors who have enjoyed almost non-stop gains from the sector. But now, cost pressures are now putting heat on the sector and gains have been much harder to come by. In contrast, the party’s just beginning for China… Chinese health care is far earlier on the growth curve and appears to have a long growth path ahead of itself. Chinese per-capita spending on health care is the lowest of any of the 20 largest global economies. Off that low base, key companies look set to grow at a double-digit clip for a number of years to come and offer investors the same consistent gains once offered by American healthcare stocks. Here are three companies I’ve found that appear nicely positioned to capitalize on that trend. 1. American Oriental Bioengineering (AMEX: AOB) Growing through acquisitions can be winning strategy if it helps a company develop a broad and compelling set of products. That was the plan for this purveyor of plant-based drugs and neutraceuticals. Chinese consumers greatly prefer traditional organic remedies,… Read More